Clinical trials
Phase 2/3 Breast Neoplasms trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AC Camargo Cancer Center | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Hoffmann-La Roche | 1 |
| Novartis Pharmaceuticals | 1 |
| Universidade Federal de Goias | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 6 |
| Triple Negative Breast Neoplasms | 2 |
| Hereditary Sensory and Autonomic Neuropathies | 1 |
| Neoplasm Metastasis | 1 |
| Radiation Injuries | 1 |
| Radiodermatitis | 1 |
| Seroma | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.